Published in Clin Vaccine Immunol on August 17, 2006
Production and evaluation of antibodies and phage display-derived peptide ligands for immunomagnetic separation of Mycobacterium bovis. J Clin Microbiol (2012) 0.88
Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform. Curr Opin Virol (2015) 0.79
Detection of Mycobacterium tuberculosis based on H37R(v) binding peptides using surface functionalized magnetic microspheres coupled with quantum dots – a nano detection method for Mycobacterium tuberculosis. Int J Nanomedicine (2014) 0.78
A novel B-cell epitope identified within Mycobacterium tuberculosis CFP10/ESAT-6 protein. PLoS One (2013) 0.77
Real-time Recognition of Mycobacterium tuberculosis and Lipoarabinomannan using the Quartz Crystal Microbalance. Sens Actuators B Chem (2012) 0.77
A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens. Clin Exp Immunol (2015) 0.76
Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine. PLoS One (2015) 0.75
A novel Omp25-binding peptide screened by phage display can inhibit Brucella abortus 2308 infection in vitro and in vivo. J Med Microbiol (2014) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The envelope of mycobacteria. Annu Rev Biochem (1995) 9.33
Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1995) 4.76
Phage Display. Chem Rev (1997) 4.57
The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis (1987) 3.67
Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. Trends Microbiol (2001) 3.58
Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol (2002) 3.32
Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun (2000) 3.24
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun (2000) 2.87
Nonrandom utilization of codon pairs in Escherichia coli. Proc Natl Acad Sci U S A (1989) 2.81
Heterogeneous antibody responses in tuberculosis. Infect Immun (1998) 2.54
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun (1992) 2.33
Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J Biol Chem (1992) 2.28
A comparison of seven tests for serological diagnosis of tuberculosis. J Clin Microbiol (2000) 2.27
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods (2001) 2.07
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
Serological diagnosis of tuberculosis. Eur Respir J Suppl (1995) 1.93
Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol (2004) 1.81
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am J Respir Crit Care Med (1997) 1.55
A library of organic landscapes on filamentous phage. Protein Eng (1996) 1.53
TB vaccines: progress and problems. Trends Immunol (2001) 1.50
Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol (1998) 1.46
Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis. Clin Diagn Lab Immunol (2002) 1.46
Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins. Biochemistry (1973) 1.45
Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect (1999) 1.43
Effective cancer therapy through immunomodulation. Annu Rev Med (2006) 1.26
Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology (2002) 1.23
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. J Immunol (1999) 1.23
The mycobacterial cell wall: structure, biosynthesis and sites of drug action. Curr Opin Chem Biol (1997) 1.22
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front Biosci (2004) 1.19
Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Scand J Infect Dis (2002) 1.19
Entry and survival of pathogenic mycobacteria in macrophages. Microbes Infect (2001) 1.17
Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Clin Infect Dis (2002) 1.15
Identifying diagnostic peptides for lyme disease through epitope discovery. Clin Diagn Lab Immunol (2001) 1.11
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection. J Clin Microbiol (2004) 1.05
Lung cancer immunotherapy. Clin Med Res (2005) 1.04
Structural basis of peptide-carbohydrate mimicry in an antibody-combining site. Proc Natl Acad Sci U S A (2003) 1.04
Treatment of tuberculosis: present status and future prospects. Bull World Health Organ (2005) 1.04
Comparison of antibody responses to a potential combination of specific glycolipids and proteins for test sensitivity improvement in tuberculosis serodiagnosis. Clin Diagn Lab Immunol (2004) 1.03
Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur J Immunol (1993) 0.98
Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin Diagn Lab Immunol (1998) 0.96
Antigen mining with iterative genome screens identifies novel diagnostics for the Mycobacterium tuberculosis complex. Clin Vaccine Immunol (2006) 0.94
Single framework recombinant antibody fragments designed for protein chip applications. Biotechniques (2002) 0.93
A new rapid and simple method for large-scale purification of mycobacterial lipoarabinomannan. FEMS Immunol Med Microbiol (1999) 0.92
Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect Immun (1997) 0.90
A PE protein expressed by Mycobacterium avium is an effective T-cell immunogen. Infect Immun (2006) 0.90
Serodiagnosis of tuberculosis: comparison of immunoglobulin A (IgA) response to sulfolipid I with IgG and IgM responses to 2,3-diacyltrehalose, 2,3,6-triacyltrehalose, and cord factor antigens. J Clin Microbiol (2002) 0.89
The multiple antigen blot assay (MABA): a simple immunoenzymatic technique for simultaneous screening of multiple antigens. Immunol Lett (1998) 0.88
Peptide mimotopes of Mycobacterium tuberculosis carbohydrate immunodeterminants. Biochem J (2005) 0.87
The binding peoperties of anti-phosphorylcholine mouse myeloma proteins as measured by protein fluorescence. J Biol Chem (1973) 0.86
Antagonists of Hsp16.3, a low-molecular-weight mycobacterial chaperone and virulence factor, derived from phage-displayed peptide libraries. Appl Environ Microbiol (2005) 0.80
Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens. Cell Mol Biol (Noisy-le-grand) (2003) 0.78
BCG immunotherapy--from pathophysiology to clinical practice. Expert Opin Drug Saf (2006) 0.78
Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect Immun (2002) 1.32
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology (2009) 1.18
Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol (2009) 1.15
Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis (2002) 1.08
Rupture of rudimentary uterine horn pregnancy at 37 weeks gestation with fetal survival. Arch Gynecol Obstet (2006) 1.07
The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8. PLoS Pathog (2013) 1.00
H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence. J Virol (2013) 1.00
In vitro nicotine-induced oxidative stress in mice peritoneal macrophages: a dose-dependent approach. Toxicol Mech Methods (2009) 0.98
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release (2010) 0.98
CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response. J Infect Dis (2009) 0.98
The S4-intermediate pathway for the oxidation of thiosulfate by the chemolithoautotroph Tetrathiobacter kashmirensis and inhibition of tetrathionate oxidation by sulfite. Res Microbiol (2007) 0.96
Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis. PLoS Pathog (2011) 0.96
Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. J Virol (2010) 0.94
Eugenol protects nicotine-induced superoxide mediated oxidative damage in murine peritoneal macrophages in vitro. Eur J Pharmacol (2009) 0.94
The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation. PLoS Pathog (2012) 0.93
Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway. Int Immunopharmacol (2008) 0.93
Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. J Antimicrob Chemother (2012) 0.93
Reciprocal regulation of protein kinase C isoforms results in differential cellular responsiveness. J Immunol (2012) 0.93
Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice. Med Microbiol Immunol (2011) 0.93
Alteration of immune functions and Th1/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine. Int Immunopharmacol (2011) 0.92
CXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells. PLoS One (2012) 0.91
Arabinosylated lipoarabinomannan-mediated protection in visceral leishmaniasis through up-regulation of toll-like receptor 2 signaling: an immunoprophylactic approach. J Infect Dis (2010) 0.91
The dimeric repressor SoxR binds cooperatively to the promoter(s) regulating expression of the sulfur oxidation (sox) operon of Pseudaminobacter salicylatoxidans KCT001. Microbiology (2007) 0.91
Origin binding activity of the Mycobacterial plasmid pAL5000 replication protein RepB is stimulated through interactions with host factors and coupled expression of repA. J Bacteriol (2002) 0.91
Leishmania donovani-induced ceramide as the key mediator of Akt dephosphorylation in murine macrophages: role of protein kinase Czeta and phosphatase. Infect Immun (2007) 0.89
Arabinosylated lipoarabinomannan skews Th2 phenotype towards Th1 during Leishmania infection by chromatin modification: involvement of MAPK signaling. PLoS One (2011) 0.89
Modulation of DNA-binding activity of Mycobacterium tuberculosis HspR by chaperones. Microbiology (2008) 0.89
Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity. J Antimicrob Chemother (2008) 0.87
Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression. J Virol (2014) 0.87
DnaK dependence of the mycobacterial stress-responsive regulator HspR is mediated through its hydrophobic C-terminal tail. J Bacteriol (2012) 0.86
An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages. Glycoconj J (2006) 0.86
Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages. PLoS One (2011) 0.85
Phages specific for mycobacterial lipoarabinomannan help serodiagnosis of tuberculosis. New Microbiol (2009) 0.84
Leaf extract of Moringa oleifera prevents ionizing radiation-induced oxidative stress in mice. J Med Food (2011) 0.83
Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9. Int Immunopharmacol (2012) 0.83
Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis. Infect Immun (2005) 0.83
Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis: involvement of TLR4 signalling. J Antimicrob Chemother (2012) 0.82
The mycobacteriophage D29 gene 65 encodes an early-expressed protein that functions as a structure-specific nuclease. J Bacteriol (2008) 0.82
Conjugative Type 4 secretion system of a novel large plasmid from the chemoautotroph Tetrathiobacter kashmirensis and construction of shuttle vectors for Alcaligenaceae. Appl Environ Microbiol (2009) 0.82
Arabinosylated lipoarabinomannan modulates the impaired cell mediated immune response in Mycobacterium tuberculosis H37Rv infected C57BL/6 mice. Microbes Infect (2007) 0.81
Tumor-derived vascular pericytes anergize Th cells. J Immunol (2013) 0.81
TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages. Carcinogenesis (2011) 0.80
Chaperone-mediated inhibition of tubulin self-assembly. Proteins (2007) 0.80
Antagonists of Hsp16.3, a low-molecular-weight mycobacterial chaperone and virulence factor, derived from phage-displayed peptide libraries. Appl Environ Microbiol (2005) 0.80
Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite. J Infect Dis (2012) 0.80
Immunomodulatory role of arabinosylated lipoarabinomannan on Leishmania donovani infected murine macrophages. Indian J Biochem Biophys (2007) 0.80
Translational coupling to an upstream gene promotes folding of the mycobacterial plasmid pAL5000 replication protein RepB and thereby its origin binding activity. J Bacteriol (2004) 0.79
Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12. PLoS One (2012) 0.78
Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice. Food Funct (2013) 0.78
Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide. Indian J Exp Biol (2009) 0.78
Genome implosion elicits host-confinement in Alcaligenaceae: evidence from the comparative genomics of Tetrathiobacter kashmirensis, a pathogen in the making. PLoS One (2013) 0.77
Amphotericin B regulates the host immune response in visceral leishmaniasis: reciprocal regulation of protein kinase C isoforms. J Infect (2010) 0.77
DNA bending in the mycobacterial plasmid pAL5000 origin-RepB complex. J Bacteriol (2007) 0.77
Radio-attenuated leishmanial parasites as immunoprophylactic agent against experimental murine visceral leishmaniasis. Exp Parasitol (2011) 0.77
Mycobacteriophage L5Gp56, a novel member of the NrdH family of redoxins. FEMS Microbiol Lett (2014) 0.76
Lipoarabinomannan-induced cell signaling involves ceramide and mitogen-activated protein kinase. Clin Diagn Lab Immunol (2002) 0.76
Evolutionary link between the mycobacterial plasmid pAL5000 replication protein RepB and the extracytoplasmic function family of σ factors. J Bacteriol (2012) 0.76
Optimization of the sublethal dose of silver nanoparticle through evaluating its effect on intestinal physiology of Nile tilapia (Oreochromis niloticus L.). J Environ Sci Health A Tox Hazard Subst Environ Eng (2015) 0.75
Toll like receptor 2 and CC chemokine receptor 5 cluster in the lipid raft enhances the susceptibility of Leishmania donovani infection in macrophages. Indian J Exp Biol (2014) 0.75
Formulation and Application of Biodegradable Nanoparticles Based Biopharmaceutical Delivery - An Efficient Delivery System. Curr Pharm Des (2016) 0.75
Successful use of uterine artery embolisation to treat placenta increta in the first trimester. Arch Gynecol Obstet (2008) 0.75
Interactions of sulfur oxidation repressor with its promoters involve different binding geometries. Arch Microbiol (2012) 0.75